Related Experiment Video
Updated: Oct 14, 2025

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
A case with two faces: noncompaction or phospholamban cardiomyopathy?
Sip Wijchers1, Jan H von der Thüsen2, Jan Lukas Robertus3
1Department of Cardiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
A rare phospholamban gene mutation caused severe noncompaction cardiomyopathy in a 15-year-old girl, leading to heart failure and transplant. This highlights the importance of genetic testing for such cases.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Noncompaction cardiomyopathy is a recognized cardiac condition.
- Phospholamban gene mutations are increasingly linked to cardiomyopathies.
Observation:
- A 15-year-old female presented with rapidly progressing heart failure.
- Cardiovascular imaging confirmed noncompaction cardiomyopathy.
Findings:
- Genetic testing revealed a phospholamban gene mutation.
- The patient underwent heart transplantation due to end-stage heart failure.
Implications:
- This case underscores the critical role of phospholamban gene mutation analysis in severe noncompaction cardiomyopathy.
- Early genetic diagnosis can inform prognosis and management strategies for inherited cardiomyopathies.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

